Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STI MedSorb was a specialized medical device manufacturer focused on the development and production of surgical sutures and wound closure components. Based in Reading, Pennsylvania, the company established itself as a key provider of both absorbable and non-absorbable suture materials, including polyglycolic acid and polydioxanone. STI MedSorb primarily operated as a contract manufacturing organization, supplying high-quality needle-suture combinations to global medical device brands. In 2011, the company's assets were acquired by Surgical Specialties Corporation to enhance its internal manufacturing capabilities and product offerings. Following subsequent mergers, the legacy of STI MedSorb's technology now resides within Corza Medical. The company was highly regarded for its expertise in material science and precision engineering for surgical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sti-Medsorb.